Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
For more information, visit: http://www.cancertypeid.com
Advertisement
Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
For more information, visit: http://www.cancertypeid.com